По следам XXIII Российского онкологического конгресса: дискуссия «Станет ли вся лучевая терапия протонной?»

По следам XXIII Российского онкологического конгресса: дискуссия «Станет ли вся лучевая терапия протонной?»

Автор: Деньгина Н. В., Митин Т. В., Воробьв Н. А.

Журнал: Злокачественные опухоли @malignanttumors

Рубрика: Дискуссионные вопросы в онкологии

Статья в выпуске: 4 т.9, 2019 года.

Бесплатный доступ

В статье представлены два мнения в отношении протонной лучевой терапии, ее физических основ, дозиметрических особенностей и клинической эффективности в сравнении с более традиционным фотонным облучением, а также мнение авторов в отношении целесообразности расширения показаний к протонной терапии и открытия новых центров по лечению протонами в мире. Данный обзор стал продолжением дискуссионной сессии по протонной терапии, состоявшейся на XXIII Российском онкологическом конгрессе в ноябре 2019 года.

Протонная терапия, фотонная лучевая терапия

Короткий адрес: https://sciup.org/140249285

IDR: 140249285   |   DOI: 10.18027/2224-5057-2019-9-4-5-17

Список литературы По следам XXIII Российского онкологического конгресса: дискуссия «Станет ли вся лучевая терапия протонной?»

  • Климанов В. А. Радиобиологическое и дозиметрическое планирование лучевой и радионуклидной терапии. Часть 2. Лучевая терапия пучками протонов, ионов, нейтронов и пучками с модулированной интенсивностью, стереотаксис, брахитерапия, радионуклидная терапия, оптимизация, гарантия качества. Учебное пособие. М.: НИЯУ МИФИ. - 2011.
  • https://cerncourier.com / a / the-changing-landscape-of-cancer-therapy
  • Brown AP et al. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86 (2):277 - 84. 10.1016 / j. ijrobp. 2013.01.014. DOI: 10.1016/j.ijrobp.2013.01.014
  • Zorlu F, Gurkaynak M, Yildiz F, et al. Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol Sci. 2000;21:203 - 207.
  • Santoni R, Liebsch N, Finkelstein DM, et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys. 1998;41:59 - 68.
  • Ares C, Hug EB, Lomax AJ, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: First long-term report. Int J Radiat Oncol Biol Phys. 2009;75:1111 - 1118.
  • Rombi B, Ares C, Hug EB, et al. Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: Clinical outcome of 26 patients treated at Paul Scherrer Institute. Int J Radiat Oncol. 2013;86:578 - 584.
  • McDonald MW, Linton OR, Shah MV. Proton therapy for reirradiation of progressive or recurrent chordoma. Int J Radiat Oncol Biol Phys. 2013;87:1107 - 1114.
  • Schild SE, McGinnis WL, Graham D, et al. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65 (4):1106 - 1111.
  • Bradley JD, Paulus R, Komaki R, et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy + / - cetuximab for stage IIIA / IIIB non-small cell lung cancer: preliminary findings on radiation dose in RTOG 0617 [abstract]. 53rd Annual Meeting of the American Society for Radiation Oncology, 2011.
  • Cox JD: Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys. 2012;82 (3):1042 - 1044.
  • Sejpal S, Komaki R, Tsao A, et al. Early Findings on Toxicity of Proton Beam Therapy with Concurrent Chemotherapy in Non-small Cell Lung Cancer. Cancer 2011;117:3004 - 3013.
  • Van de Water TA, Lomax AJ, Bijl HP, et al. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011;79:1216 - 1224.
  • Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80:263 - 267.
  • Miralbell R, Crowell C, Suit HD. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys. 1992;22:305 - 310.
  • Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54:824 - 829.
  • Van de Water TA, Lomax AJ, Bijl HP, et al. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012;82: e313-e319.
  • Yoon M, Ahn SH, Kim J, et al. Radiation-induced cancers from modern radiotherapy techniques: Intensity-modulated radiotherapy proton therapy. Int J Radiat Oncol Biol Phys. 2010;77:1477 - 1485.
  • Weber DC, Chan AW, Lessell S, et al. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons / protons. Radiother Oncol. 2006;81:243 - 249.
  • Takeda A, Shigematsu N, Suzuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: Relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys. 1999;44:599 - 605.
  • Katz TS, Mendenhall WM, Morris CG, et al. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002;24:821 - 829.
  • Mock U, Georg D, Bogner J, et al. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:147 - 154.
  • Okano S, Tahara M, Zenda S, et al. Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies. Jpn J Clin Oncol. 2012;42:691 - 696.
  • Truong MT, Kamat UR, Liebsch NJ, et al. Proton radiation therapy for primary sphenoid sinus malignancies: Treatment outcome and prognostic factors. Head Neck. 2009;31:1297 - 1308.
  • Van der Laan HP, van de Water TA, van Herpt HE, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. Acta Oncol. 2013;52:561 - 569.
  • Van de Water TA, Lomax AJ, Bijl HP, et al. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011;79:1216 - 1224.
  • Lin R, Slater JD, Yonemoto LT, et al. Nasopharyngeal carcinoma: Repeat treatment with conformal proton therapyddose- volume histogram analysis. Radiology. 1999;213:489 - 494.
  • Armstrong, G. T. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur. J. Paediatr. Neurol. 2010;14:298 - 303.
  • Mertens, A. C. et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J. Natl Cancer Inst. 2008;100:1368 - 1379.
  • Morris, E. B. et al. Survival and late mortality in longterm survivors of pediatric CNS tumors. J. Clin. Oncol. 2007;25:1532 - 1538.
  • Chung, C. S. et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int. J. Radiat. Oncol. Biol. Phys. 2013;87:46 - 52.
  • Zhang, R. et al. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother. Oncol. 2014;113:84 - 88.
  • Mu X, Bjork-Eriksson T, Nill S, et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? А comparative treatment planning study. Acta Oncol. 2005;44 (6):554 - 562.
  • Lundkvist, J., Ekman, M., Ericsson, S. R., Jonsson, B. & Glimelius, B. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol. 2005;44:850 - 861.
  • Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016 May 15;122 (10):1483 - 501.
  • https://www.astro.org / uploadedFiles / _MAIN_SITE / Daily_Practice / Reimbursement / Model_Policies / Content_ Pieces / ASTROPBTModelPolicy. pdf
  • Glimelius B, Montelius A: Proton beam therapy - Do we need the randomized trials and can we do them? Radiother Oncol 83:105 - 109, 2007
  • Goitein M, Cox JD: Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 26:175 - 176, 2008
  • Bentzen SM: Randomized controlled trials in health technology assessment: Overkill or overdue? Radiother Oncol 86:142 - 147, 2008.
  • Higgins KA, et al. National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer. Int Journal Radiat Oncol Biol Phys 2017;97 (1):128 - 137.
  • Sejpal S, et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. cancer 2011 117 (13):3004 - 13.
  • Liao Z, et al. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non - Small-Cell Lung Cancer. Journal of Clinical Oncology 2018;36 (18):1813 - 1822.
  • Wang J. et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86 (5):885 - 91.
  • Xi M. et al. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. Int J Radiat Oncol Biol Phys. 2017 Nov 1;99 (3):667 - 676.
  • Lin SH et al. Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer. ASTRO 2019.
  • Sheets NC, et al., Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 2012 Apr 18;307 (15):1611 - 20
  • Dinh, TT et al. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared To Rectal Balloon Immobilization After Proton Beam Radiotherapy For Localized Prostate Cancer, In Press.
  • Hamstra DA et al., Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiation Oncol Biol Phys 97 (5): 976 - 985, 2017.
  • Wo JH et al. A Pilot Feasibility Study of Definitive Concurrent Chemoradiation with Pencil Beam Scanning Proton Beam in Combination with 5 Fluorouracil and Mitomycin C for Carcinoma of the Anal Canal. Journal of Clinical Oncology 2018;36 (4):733 - 733.
  • Haas-Kogan D. et al. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 May 1;101 (1):152 - 168.
  • Feghali et al., Prospective Phase II Randomized Trial Comparing Proton Therapy vs Photon IMRT for newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free survival between RANO vs. Clinical and Radiological Assessment. ASTRO 2019.
  • Corkum MT et al. Online advertising and marketing claims by providers of proton beam therapy: are they guideline based? ASCO 2019 poster.
  • Beyreuther E, et al. Feasibility of proton FLASH effect tested by zebrafish embryo irradiation. Radiother Oncol. 2019 Oct;139:46 - 50.
  • Sheng K. et al. Evolution of Ipsilateral Head and Neck Radiotherapy. Current Cancer Therapy Reviews 2014;10 (4).
Еще
Статья научная
SciUp 2024 © 2024 ©